If you have symptoms of coronavirus (COVID-19) – a high temperature, a new continuous cough, or a loss of, or change in, your normal sense of smell or taste (anosmia) – the advice is to stay at home for seven days. All members of this household should remain at home for 14 days.

If you think you have symptoms, please do not attend your hospital appointment until you are advised it is safe to do so. Please contact us to rearrange your appointment, or to re-organise treatment and tests.

Restarting clinical research at NUH

Restarting clinical research at NUH

Since the COVID-19 pandemic was first declared we have taken a number of steps to protect our patients involved in clinical research. These included the suspension of non COVID-19 research trials and the safe continuation of trials providing essential clinical treatments. 

Our staff and resources were redeployed into the national priority research programme to rapidly evaluate new treatments, tests and a vaccine for COVID-19. Thousands of patients and staff have now taken part in vital COVID-19 research at NUH, for which we are incredibly grateful.

Continuing COVID-19 research

Coronavirus will be with us for some time to come and our clinical research will continue to be a vital part of finding effective treatments and the longer-term protection of our families and communities. We will remain flexible, so that we can respond to changes in COVID-19 infection rates and the more localised information from the NHS test and trace service.

Research Restart

As the number of COVID-19 cases continues to reduce, we are able to release some staff, resources and facilities back to the delivery of our planned programme of clinical research, whilst maintaining our COVID-19 research. This will enable us to increasingly restart trials and to develop new studies which meet the important health needs of our patients and communities. 

We are putting the safety of our patients and our staff as the number one priority in restarting our research.

Safety of patients

We are working very hard to ensure that you can participate in research safely and in line with public health advice to reduce the spread of Coronavirus. The safety measures we are putting in place include:

  • All of our research facilities have measures in place to minimise any risk from Coronavirus including increased hygiene regimes, COVID-19-free areas and adaptation of facilites for safe clinical practice
  • Our research teams have undertaken additional training in the use of protective equipment and are following detailed guidelines on infection control
  • Your research appointments will as far as possible continue to use video consultation, or take place over the phone, or use other measures to avoid unnecessary travel and contact
  • If a face-to-face appointment is needed we will follow social distancing rules and the safety measures put in place across our hospitals to protect you - including the wearing of face masks by all staff and face coverings by patients

If you have been taking part in a research trial that was suspended, your research team will be in contact over the next few weeks to let you know when it will restart and what we will do to keep you safe.

In the meantime, if you have comments or questions about restarting clinical research at NUH, please email us at: Getinvolved@nuh.nhs.uk

Restart process for researchers

In order to prioritise the trials and studies which we are able to restart, our Research & Innovation department has put in place a Restart Research process so that Principal Investigators, research teams and frontline research delivery staff have clarity about restarting, or opening new, trials.

We have produced a number of documents to explain this process and the actions that Principal Investigators and research teams should now take to restart research. These are available to read and download in the drop down menu  - Documents - below.

National prioritisation

Our plans are being developed in line with the National Institute for Health Research restart framework https://www.nihr.ac.uk/documents/restart-framework/24886 and guidance from the Government including how to travel safely and working in indoor labs and research facilities and similar environments

For more information

If you are a Principal Investigator or a researcher involved in clinical research at Nottingham University Hospitals, the NIHR Nottingham Biomedical Research Centre or the NIHR Nottingham Clinical Research Facility please email us if you have any questions about the Research Restart process.


Explaining the restart process

The process for Research Restart is explained in the document below. Please read this before completing the Study Restart document.

Research Restart Process A4-v2.pdf [pdf] 90KB

Please complete and return

Please complete the Study Restart document below, to request the resumption or the initiation of your research.

To help you complete your request

This guidance document aims to provide additional information to help you complete the Study Research document.

Study Restart Document Guidance A4-v2.pdf [pdf] 100KB

Frequently Asked Questions

The latest version of FAQs on Research Restart are available below:

Restart Research FAQs A4-v2.pdf [pdf] 183KB

Staffing Plan

The latest version of the staff resource plan will be published here.

Information for patients and carers

Please find below information you may find useful for sharing with patients. Please click on the link to view or download.

Attending for appointments at NUH

Documents will posted here shortly.

NIHR guidelines on virtual involvement

Virtual involvement_FINAL.pdf [pdf] 555KB